Urinary Tract Infection
exp date isn't null, but text field is
Urinary tract infection (UTI) is the presence of micro-organisms in the urine or tissues of the normally sterile genitourinary tract. Infection may be localized to the bladder alone or the kidneys or, in men the prostate.
Acute uncomplicated UTI occurs in women with a normal genitourinary tract and usually manifests as acute cystitis (bladder infection or lower tract infection). Complicated UTI occurs in individuals with structural or functional abnormalities of the genitourinary tract, including those with indwelling devices such as urethral catheters.
Congenital abnormalities of the genito-urinary tract predispose children to UTI. Proven UTI in a child or recurrent UTI requires further urogenital evaluation.
Definitive treatment of UTI depends on culture and sensitivity reports. However, empirical treatment may be initiated while awaiting the report.
Cause
- Bacteraemia or septicaemia
- Urinary tract obstruction e.g. enlarged prostate in adult males, posterior urethral valves in infants/children
Symptoms
- Frequent painful urination
- Haematuria
- Cloudy/foul smelling urine
- Vomiting
- Suprapubic pain
- Fever - may be persistent and unexplained (in children)
- There may be feeding problems, diarrhoea, and failure to thrive as well (in children)
Note: UTI symptoms can be non-specific in young children.
Signs
- Fever
- Loin tenderness
- Suprapubic tenderness
- Foul smelling urine
Investigations
- FBC
- Mid-stream specimen of urine for microscopy, culture and sensitivity (re-culture urine after treatment)
- Abdominal ultrasound scan in children if indicated
TreatmentTreatment Objectives
- To relieve symptoms such as fever and pain (See section on ‘Fever’ and ‘Pain Management’)
- To eradicate causative agent
- To prevent complications
- To identify patients with abnormalities of the genito-urinary tract
Non-pharmacological treatment
Liberal oral fluids to encourage good urinary output
Personal hygiene and proper cleaning after defaecation
Pharmacological treatment
Treatment of Uncomplicated UTI
1st Line Treatment
Evidence Rating: [C]
- Ciprofloxacin, oral,
Adults
500 mg 12 hourly for 7 days (female); 10-14 days (male)
Children
15-20 mg/kg 12 hourly; (max. of 750 mg daily in two divided doses)
Or
- Cefuroxime, oral,
Adults
250-500 mg 12 hourly for 5-7 days (female); 10-14 days (male)
Children
12-18 years; 250 mg 12 hourly for 5-7 days
2-12 years; 15 mg/ kg 12 hourly (max. 250 mg) for 5-7 days
3 months-2 years; 10 mg/kg 12 hourly (max. 125 mg) for 5-7 days
Treatment of Complicated UTI (including catheter-related, stones, prostate enlargement, urologic abnormalities and pregnancy)
1st Line Treatment
Evidence Rating: [C]
- Ciprofloxacin, IV,
Adults
400 mg 8-12 hourly for 7 days (to be administered over 60 minutes)
Or
- Gentamicin, IV, (if kidney function is normal)
Adults
40-80 mg 8 hourly for 7 days
Children
12-18 years; 2 mg/kg 8 hourly for 7 days
1 month-12 years; 2.5 mg/kg 8 hourly for 7 days
Or
- Ceftriaxone, IV,
Adults
1-2 g daily for 7 days
Children
All ages 25 mg/kg 12 hourly (max. 75 mg/kg daily)
Or
- Amoxicillin + Clavulanic Acid, IV,
Children
1 month-18 years; 20-30 mg/kg 8 hourly (max. 500 mg) for 5-7 days
Neonates (dose doubled in severe infection)
7-28 days; 30 mg/kg 8 hourly for 5-7days
< 7 days; 30 mg/kg 12 hourly for 5-7days
And
- Gentamicin, IV, (slow intravenous injection over at least 3 minutes)
Children
12-18 years; 2 mg/kg 8 hourly
1 month-12 years; 2.5 mg/kg 8 hourly
Or
- Cefuroxime, IV,
Children
1 month-18 years; 20 mg/kg 8 hourly max. 750 mg, (increase to 40-50 mg/kg max. 1.5g 6-8 hourly in severe infections)
Neonates (double the dose in severe infections, IV route only)
21-28 days; 25 mg/kg 6 hourly
7-12 days; 25 mg/kg 8 hourly
< 7 days; 25 mg/kg 12 hourly
Referral Criteria
Refer patients who are very ill, with recurrent UTI, persistent haematuria and congenital abnormalities to the appropriate specialist